Pain management Flashcards
Indications for rotating opioids
- dose-limiting side effects (sedation, nausea, pruritis, myoclonus)
- Need for new dosing route
- Cost/insurance changes
- Inadequate analgesia despite dose escalation of current opioid
Brief pain inventory
assesses pain influence and mood and function
McGill Pain Questionnaire
Evaluates pain qualities
Methylnatrexone MOA
mu-opioid receptor antagonist
Reversed opioid induced constipation and urinary retention and pruritis.
MOA and use clonidine
alpha 2 adrenergic agonist
Used as neuraxial adjuvant – reduces concentration of local anesthetic need
increases duration of sensory block
decreased adrenal stress response
SE: hypotension, sedation, bradycardia
CYP450 inhibitors
Sodium valproate
Isoniazid
Cimetidine
Ketoconazole
Fluconazole
Alcohol & Grapefruit juice
Chloramphenicol
Erythromycin
Sulfonamides
Ciprofloxacin
Omeprazole
Metronidazole
CYP450 inducers
Carbemazepines
Rifampicin
Alcohol
Phenytoin
Griseofulvin
Phenobarbitone
Sulphonylureas
CYP2D6 inhibitors
Bupropion
Dacomitinib
Fluoxetine
Paroxetine
Quinidine
Tipranavir
Medications metabolized by CYP2D6
Amitriptyline, clozapine, desipramine, flecainide, haloperidol, nortriptyline, risperidone, and valbenazine
Neuraxial conversions
Morphine
PO 300
IV 100
epidural 10
intrathecal 1
(fentanyl IV 15:1 intrathecal, 3:1 epidural)
Use of Behavioral pain scale
For critically ill pts
which opioids have no phase one metabolism with CYP450
Oxy, morphine, hydromorphone
Metabolism of gabapentin
Renally excreted
peak concentration 2-3 hr
Pathophys of hyperalgesia caused by chronic opioid use
Increased neuronal activity in dorsal horn
Sensitization of afferent neurons
Increased expression of substance P
Nerve block for pancreatic cancer, distal 2/3 esophagus to transverse colon
Celiac plexus block (T12-L1)
or splanchnic nerve block (for visceral pain; T5-T12)
Nerve block for descending colon to rectum and urogenital
Superior hypogastric plexus block